Skip to main content
. 2000 Apr 24;2000(2):CD002139. doi: 10.1002/14651858.CD002139

c06 MCL‐1.

Methods RCT ‐ 1980‐84
Participants 52 patients
Interventions radical radiotherapy vs radical radiotherapy + chemotherapy
 doxorubicin 40
 lomustine* 30
 cyclophosphamide 400
 methotrexate 30
Outcomes survival
Notes chemotherapy given until tumour progression or toxicity
 radiotherapy 55 Gy in 25 fractions**
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Low risk A ‐ Adequate